Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Reference Guide
  /  
4-Hydroxybutyric Acid
Sign up free to test for 
4-Hydroxybutyric Acid
.
One login for 30+ lab companies.

4-Hydroxybutyric Acid

4-Hydroxybutyric acid, commonly known as gamma-hydroxybutyric acid (GHB), is an organic acid with the chemical formula C4H8O3. This small molecule functions as both a neurotransmitter and a depressant drug within the body. 

Naturally synthesized from gamma-aminobutyric acid (GABA) by the enzyme GABA-transaminase, GHB is subsequently metabolized to succinic semialdehyde by succinic semialdehyde reductase. 

Additionally, GHB can be formed from the precursors 1,4-butanediol and gamma-butyrolactone, which are sometimes used illicitly for GHB production.

In its natural form, GHB is present in small quantities in foods like beef, citrus fruits, wines, and beers due to fermentation processes.  It also appears as a microbial metabolite in bacteria such as Aeromonas, Escherichia, and Pseudomonas

Clinically, GHB is utilized as a general anesthetic and for treating conditions like cataplexy, narcolepsy, and alcoholism.  However, it is also known for its misuse as a recreational drug, performance enhancer, and in drug-facilitated crimes due to its sedative and euphoric effects. 

Elevated levels of GHB can act as a neurotoxin, influencing GABA and glutamate signaling, and leading to symptoms such as headaches, confusion, fatigue, and seizures.

What is GHB (4-Hydroxybutyric Acid)?  [9.] 

4-Hydroxybutyric acid, also known as gamma-hydroxybutyric acid (GHB), is a naturally occurring compound with the chemical formula C4H8O3.  It is a small molecule that acts as a neurotransmitter and a depressant drug in the body. 

It is synthesized from GABA by the enzyme GABA-transaminase and subsequently metabolized to succinic semialdehyde by the enzyme succinic semialdehyde reductase.

While the primary synthesis pathway of GHB involves the conversion of GABA to succinic semialdehyde by GABA-transaminase, followed by the reduction of succinic semialdehyde to GHB by succinic semialdehyde reductase. 

Additionally, GHB can be formed from 1,4-butanediol and gamma-butyrolactone, which are precursors used in the illicit production of GHB.  [2.]  Gamma-butyrolactone is a solvent found in floor cleaning products, nail polish, and superglue removers.  [5.] 

At high doses, GHB inhibits the CNS, inducing sleep and respiratory depression, while at lower doses, it produces euphoric effects.

While found naturally in small quantities in foods like beef, citrus fruits, wines, and beers due to fermentation processes, GHB can also be produced endogenously from GABA or succinic semialdehyde as described above.

4-Hydroxybutyric acid is also a microbial metabolite found in Aeromonas, Escherichia, and Pseudomonas.

Functions and Uses of 4-Hydroxybutyric Acid  [2., 9.] 

4-Hydroxybutyric acid, or GHB, acts as a neurotransmitter and a depressant drug in the body. GHB is a precursor and metabolite of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).  

It mediates its effects through GABA and GHB-specific receptors, or by affecting dopamine transmission, acting as a direct agonist at GHB and GABA-B receptors, and indirectly at GABA-A receptors after being metabolized to GABA.  [2.] 

Clinically, it is used as a general anesthetic and for treating conditions like cataplexy, narcolepsy, and alcoholism, but it is also used illicitly as a recreational drug, performance-enhancing drug, and date rape drug due to its sedative and euphoric effects.  [5.]   

4-Hydroxybutyric Acid Toxicity  [9.] 

At high doses, 4-Hydroxybutyric acid or GHB is a neurotoxin, a metabolic toxin, and an acidifier.  

In adults, acidosis or acidemia manifests with symptoms such as headaches, confusion, fatigue, tremors, drowsiness, and seizures.

As a neurotoxin, GHB influences both GABA and glutamate signaling. The metabolism of glutamine may also contribute to the pathophysiology associated with high levels of GHB.

Elevated GHB levels have been shown to depress the functions mediated by NMDA and AMPA/kainate receptors, potentially altering glutamatergic excitatory synaptic transmission. 

4-Hydroxybutyric acid is a microbial metabolite found in Aeromonas, Escherichia, and Pseudomonas.

Degradation Pathways  [6.]

 GHB (gamma-hydroxybutyric acid) is rapidly metabolized by the enzyme gamma-hydroxybutyric acid dehydrogenase to succinic semialdehyde. Succinic semialdehyde is then further metabolized to succinic acid by the enzyme succinic semialdehyde dehydrogenase. 

Succinic acid acts as a key intermediate or "mediator" in the citric acid cycle, which is a crucial metabolic pathway for energy production in cells.

Clinical Applications and Significance

Drug-Facilitated Crimes  [7.] 

4-Hydroxybutyric Acid (GHB) has been implicated in drug-facilitated crimes, such as sexual assaults and robberies, due to its sedative and amnesic effects. Quantifying GHB levels in biological samples can assist in identifying victims and perpetrators in such cases.

Alcohol and Substance Abuse  [5., 9.]

Elevated GHB levels may be observed in individuals with alcohol or substance abuse disorders, as GHB is sometimes used as a recreational drug or a supplement to enhance the effects of other substances. GHB testing can help in the diagnosis and monitoring of these conditions.

Neurological Disorders  [10.]

Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare genetic disorder characterized by accumulation of GHB and other metabolites.  It causes a 30-fold increase of GHB and a 2-4 fold increase of GABA in the brains of patients with SSADH deficiency as compared to normal brain concentrations of the compounds.  [9.] 

In the study on succinic semialdehyde dehydrogenase deficiency (SSADHD), 4-hydroxybutyric acid (GHB) is identified as a hallmark metabolite of the disorder, which is also known as 4-hydroxybutyric aciduria.  [10.] 

SSADHD results from a disruption in the gamma-aminobutyric acid (GABA) pathway, where succinic semialdehyde (SSA) is converted into GHB instead of being further metabolized into succinic acid. 

This leads to the accumulation of GHB in the urine, blood, and cerebrospinal fluid (CSF) of patients.

The study found significant elevations of GHB and another metabolite, 4,5-dihydroxyhexanoic acid (4,5-DHHA), in the CSF of SSADHD patients compared to controls.  [10.]  GHB levels were markedly increased, highlighting its diagnostic value for SSADHD. 

Additionally, the intensities of GHB and 4,5-DHHA in plasma and urine correlated with the clinical severity of epilepsy and psychiatric symptoms in SSADHD patients, indicating that higher levels of these biomarkers were associated with less severe symptoms. 

What Are Organic Acids?  [3., 4.]

Organic acids are organic compounds with acidic properties.  They include a variety of functional groups like carboxyl, phenol, enol, and thiol, with carboxylic acids having the strongest acidity.

Organic acids are considered weak acids, with those containing phenol, enol, alcohol, or thiol groups being even weaker.  

Their structures vary in terms of carbon chain types—aromatic, aliphatic, alicyclic, heterocyclic—saturation, substitutions, and the number of functional groups. 

These acids play critical roles in metabolic and catabolic pathways, notably in the tricarboxylic acid cycle inside mitochondria, which is central to energy production in eukaryotes.  They are also pivotal in determining the sensory properties of fruits and vegetables.

Organic Acid Disorders  [1., 12.]

Organic acid disorders are inherited metabolic conditions that affect the enzymes or transport proteins essential for the breakdown of amino acids, lipids, or carbohydrates. They are marked by the excessive excretion of non-amino organic acids in urine, primarily due to defects in specific enzymes involved in amino acid breakdown that cause buildup of organic acids in tissues.

Conditions can manifest as inborn metabolic disorders of organic acids and amino acids, urea cycle anomalies, and mitochondrial respiratory chain deficiencies.

These disorders are typically passed down through autosomal recessive inheritance.  They often present in newborns with symptoms like vomiting and lethargy, progressing to more severe neurological symptoms. 

Early diagnosis and intervention are critical and can improve outcomes. Diagnostic methods include urine organic acid analysis via gas chromatography-mass spectrometry (GC/MS). 

Current treatments focus on managing symptoms and preventing complications, although definitive therapies are still under research.  Treatment focuses may include dietary management, detoxifying harmful metabolites, and in severe cases, organ transplantation. 

Continuous monitoring and management are essential for managing symptoms and preventing complications.

Organic Acids and the Microbiome  [8.]

Increasingly, research highlights new relationships between the microbiome and human health.  Many organisms that comprise the microbiome produce organic acids that can then be tested for additional diagnostic capability.  

Certain organic acids in urine like hippuric acid, benzoic acid, and indoleacetic acid are metabolites produced by gut bacteria from the breakdown of amino acids, dietary polyphenols, and other substances. 

These acids provide insights into gut health and metabolic functions.  For example, elevated levels of certain acids may indicate gut dysbiosis or specific metabolic imbalances, such as phenylketonuria. 

Some organic acids known to be produced by the microbiome include: 

Benzoic Acid (BA): 

Produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.

Hippuric Acid (HA):

Formed in the liver by conjugation of benzoic acid with glycine. Elevated levels may indicate exposure to environmental toxins like toluene.

Phenylacetic Acid (PAA) and Phenylpropionic Acid (PPA): 

These acids result from phenylalanine metabolism by gut bacteria. High urinary levels can suggest dysbiosis or disorders like phenylketonuria. PAA is also associated with depression markers.

4-Hydroxybenzoic Acid (4-HBA) and 4-Hydroxyphenylacetic Acid (4-HPAA): 

Derivatives of tyrosine metabolism. 4-HBA is linked to catechin (green tea) metabolism, and 4-HPAA is useful in diagnosing small bowel diseases related to bacterial overgrowth.

3-Hydroxyphenylpropionic Acid (3-HPPA): 

A metabolite from dietary polyphenols like proanthocyanidins, indicative of robust bacterial metabolism in the intestines.

3,4-Dihydroxyphenyl Propionic Acid (3,4-DHPPA): 

Produced from dietary quinolones by clostridial species, with high levels suggesting an overgrowth.

3-Indoleacetic Acid (IAA): A breakdown product of tryptophan by gut bacteria such as Bifidobacterium and Bacteroides. Elevated levels are seen in conditions like phenylketonuria or dietary changes.

These organic acids are important markers in clinical diagnostics, helping to monitor metabolic disturbances, gut microbiota balance, and exposure to environmental toxins.

Their presence and concentration are influenced by diet, gut microbiota composition, and overall metabolic health, making them valuable indicators in clinical settings for assessing both metabolic and gastrointestinal conditions.

Organic Acid Testing in Functional Medicine

Organic Acid Testing in Functional Medicine

In functional medicine, organic acid testing is utilized to evaluate a patient's metabolic function through a simple urine test. This testing can identify metabolic imbalances that may affect a patient’s mood, energy, and overall health. 

Testing provides insights into nutrient deficiencies, dietary habits, toxic exposures, and gut microbiome activity. 

The results assist practitioners in customizing treatment plans to address specific metabolic dysfunctions and improve health outcomes. 

Additionally, it helps in assessing the impact of microbial metabolism and the efficiency of the Krebs Cycle, aiding in personalized healthcare.

Laboratory Testing for 4-Hydroxybutyric Acid

Test Information, Sampling Methods and Preparation

Laboratory testing for organic acids including 4-Hydroxybutyric acid is typically done in urine, although it can also be tested in blood.  Testing may be ordered to diagnose an inborn metabolic disorder, or to assess metabolic function and gastrointestinal health in a functional medicine setting.  

Urine samples may be collected in a clinical setting; they can also be collected at home.  Some labs recommend or require a first morning void sample, to provide a concentrated sample.  

Interpreting 4-Hydroxybutyric Acid Results

Optimal Range for 4-Hydroxybutyric Acid Testing

Generally, falling within reference ranges for organic acids is recommended, although for many of these organic acids, a level towards the lower end of the reference range is considered optimal.  

It is essential to consult with the laboratory company used for their recommended reference range for 4-hydroxybutyric acid.  

One company reports the following reference range for 4-hydroxybutyric acid, as a GABA metabolite:  </= 4.3 mmol/mol creatinine.  [11.]

Clinical Significance of Elevated Levels of 4-Hydroxybutyric Acid

Elevated levels may indicate recent medical or illicit drug use.   Alternatively, it may indicate a disorder in organic acid processing such as succinic semialdehyde dehydrogenase deficiency. 

Clinical Significance of Low Levels of 4-Hydroxybutyric Acid

Low levels of 4-hydroxybutyric acid are not considered clinically relevant.

4-Hydroxybutyric Acid Related Biomarkers and Comparative Analysis

4-Hydroxybutyric acid is typically tested along with other organic acids to gain deeper insights into metabolic pathways and physiological processes.

Organic acids that may be tested as part of a panel include: 

2-Hydroxybutyric Acid: this acid is a marker for insulin resistance and increased oxidative stress.

2-Hydroxyphenylacetic Acid: derived from phenylalanine metabolism, this acid is used as a biomarker in various metabolic assessments.

3-Hydroxybutyric Acid: a ketone body produced during fat metabolism, indicative of carbohydrate deprivation or ketogenic conditions.

3-Hydroxyisovaleric Acid: an organic acid that accumulates in leucine catabolism disorders, often elevated in maple syrup urine disease.

3-Indoleacetic Acid: a metabolite of tryptophan, it is significant in the study of serotonin pathways and plant growth regulation.

4-Hydroxybenzoic Acid: a derivative of tyrosine metabolism, it is linked to catechin (green tea) metabolism and may be produced by some intestinal bacteria.

4-Hydroxyphenylacetic Acid: a breakdown product of tyrosine, used in diagnosing disorders involving the degradation of aromatic amino acids.

5-Hydroxyindoleacetic Acid: the main metabolite of serotonin, used as a marker in the diagnosis of carcinoid syndrome.

Adipic Acid: a dicarboxylic acid that can also be formed metabolically in humans through the oxidation of certain fatty acids.

a-Keto-b-Methylvaleric Acid: an intermediate in isoleucine metabolism, which can accumulate in certain metabolic disorders.

a-Ketoisocaproic Acid: an intermediate in the metabolism of leucine, elevated in maple syrup urine disease.

a-Ketoisovaleric Acid: a breakdown product of valine metabolism, also linked to maple syrup urine disease.

a-Ketoglutaric Acid: a key intermediate in the citric acid cycle, essential for energy production and nitrogen transport.

Benzoic Acid: produced from phenylalanine and polyphenol metabolism by intestinal bacteria. High levels in urine can indicate glycine deficiency or liver dysfunction.

Cis-Aconitic Acid: an intermediate in the tricarboxylic acid cycle, formed by the dehydration of citric acid.

Citric Acid: a central compound in the citric acid cycle, crucial for energy production in cells.

Ethylmalonic Acid: this acid accumulates in ethylmalonic encephalopathy and is involved in fatty acid metabolism.

Fumaric Acid: an intermediate in the tricarboxylic acid (TCA) cycle, participating in energy production through its conversion to malate and subsequent participation in the generation of ATP.

Homovanillic Acid: a major metabolite of dopamine, used as a marker to monitor dopamine levels.

Hippuric Acid: formed from the conjugation of benzoic acid and glycine; elevated levels can indicate exposure to certain environmental toxins.

Hydroxymethylglutarate: an intermediate in leucine metabolism, also associated with disorders of ketogenesis and ketolysis.

Isocitric Acid: an isomer of citric acid and an important part of the citric acid cycle, pivotal in cellular energy production.

Kynurenic Acid: a product of tryptophan metabolism, known for its role as a neuroprotective agent.

Lactic Acid: produced from pyruvate via anaerobic metabolism, an indicator of hypoxia and strenuous exercise.

Malic Acid: a dicarboxylic acid found in fruits, and involved  in the citric acid cycle.

Methylmalonic Acid: an indicator of Vitamin B12 deficiency, it accumulates when the vitamin is deficient.

Methylsuccinic Acid: a dicarboxylic acid often involved in alternative pathways of fatty acid metabolism.

Orotic Acid: involved in the metabolism of pyrimidines, abnormalities in its levels can indicate metabolic disorders.

Pyroglutamic Acid: an uncommon amino acid derivative that can accumulate in glutathione synthesis disorders.

Pyruvic Acid: a key intersection in several metabolic pathways; its levels are crucial for assessing cellular respiration and metabolic function.

Quinolinic Acid: a neuroactive metabolite of the kynurenine pathway, elevated levels are associated with neurodegenerative diseases.

Suberic Acid: a dicarboxylic acid that is a biomarker in adipic aciduria, often studied in relation to fatty acid oxidation disorders.

Succinic Acid: a four-carbon dicarboxylic acid that plays a central role in the Krebs cycle, crucial for energy production.

Tricarballylic Acid: an organic acid that can inhibit aconitase in the citric acid cycle and is sometimes associated with glyphosate exposure.

Vanillylmandelic Acid: a metabolite of epinephrine and norepinephrine, used as a marker for neuroblastoma and other catecholamine-secreting tumors.

Order Organic Acids Testing

Click here to compare testing options and order organic acid testing. 

What's 
4-Hydroxybutyric Acid
?
If Your Levels Are High
Symptoms of High Levels
If Your Levels are Low
Symptoms of Low Levels

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register here.

Register Here
See References

[1.] Beley GJ, Anne M, Dadia DM. Nutrigenomics in the management and prevention of metabolic disorders. Elsevier eBooks. Published online January 1, 2023:209-274. doi:https://doi.org/10.1016/b978-0-12-824412-8.00006-0 

[2.] Busardò FP, Jones AW. GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome. Curr Neuropharmacol. 2015 Jan;13(1):47-70. doi: 10.2174/1570159X13666141210215423. PMID: 26074743; PMCID: PMC4462042.

[3.] Chahardoli A, Jalilian F, Memariani Z, Farzaei MH, Shokoohinia Y. Analysis of organic acids. Recent Advances in Natural Products Analysis. Published online 2020:767-823. doi:https://doi.org/10.1016/b978-0-12-816455-6.00026-3 

[4.] French D. Advances in Clinical Mass Spectrometry. Advances in Clinical Chemistry. 2017;79:153-198. doi:https://doi.org/10.1016/bs.acc.2016.09.003 

[5.] Gamma-Hydroxybutyrate Toxicity: Practice Essentials, Background, Pathophysiology. eMedicine. Published online February 2, 2022. https://emedicine.medscape.com/article/820531-overview

[6.] Jarsiah P, Roehrich J, Wyczynski M, Hess C. Phase I metabolites (organic acids) of gamma‐hydroxybutyric acid–validated quantification using GC–MS and description of endogenous concentration ranges. Drug Testing and Analysis. 2020;12(8):1135-1143. doi:https://doi.org/10.1002/dta.2820

[7.] Kapitány-Fövény M, Zacher G, Posta J, Demetrovics Z. GHB-involved crimes among intoxicated patients. Forensic Sci Int. 2017 Jun;275:23-29. doi: 10.1016/j.forsciint.2017.02.028. Epub 2017 Mar 10. PMID: 28288338.

[8.] Lee YT, Huang SQ, Lin CH, Pao LH, Chiu CH. Quantification of Gut Microbiota Dysbiosis-Related Organic Acids in Human Urine Using LC-MS/MS. Molecules. 2022 Aug 23;27(17):5363. doi: 10.3390/molecules27175363. PMID: 36080134; PMCID: PMC9457824. 

[9.] MarkerDB. markerdb.ca. Accessed May 24, 2024. https://markerdb.ca/chemicals/383

[10.] Peters TMA, Engelke UFH, de Boer S, Reintjes JTG, Roullet JB, Broekman S, de Vrieze E, van Wijk E, Wamelink MMC, Artuch R, Barić I, Merx J, Boltje TJ, Martens J, Willemsen MAAP, Verbeek MM, Wevers RA, Gibson KM, Coene KLM. Succinic semialdehyde dehydrogenase deficiency in mice and in humans: An untargeted metabolomics perspective. J Inherit Metab Dis. 2024 May;47(3):417-430. doi: 10.1002/jimd.12657. Epub 2023 Jul 29. PMID: 37455357.

[11.] Rupa Health.  1.OAT Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1lA81IDzMs3Q0myMwQR90ypXGCnFzgYGu/view

[12.] Seashore M. The Organic Acidemias: An Overview.; 2001. Accessed May 2, 2024. https://corpora.tika.apache.org/base/docs/govdocs1/141/141031.pdf 

Test for

4-Hydroxybutyric Acid

Order, track, and receive results from 30+ labs in one place.